Dallas, Texas 04/04/2014 (FINANCIALSTRENDS) – The Director of Endo International PLC(NASDAQ:ENDP) John Delucca sold 10,384 shares in the market on 1st April. $68.46 was the average price at which they were sold that made a total transaction of $710,888.64. Immediately after the sale, the director has the direct ownership of 21,596 shares. The value of which is estimated to be $1,478,462. The sale was notified to the Securities & Exchange Commission by filing the document to the commission.
The below average trading of Endo Health Solutions (NASDAQ:ENDP)
The mid-day trading was seen 0.66% down with the share price of $67.65 with 1,823,808 shares traded. Endo Health Solutions (NASDAQ: ENDP) has a 52 week low and high of 31.81$ and 82.16$ respectively. The market capital of this stock is $7.822 billion. There was also a noticeable decrease in the short interest in January. Till 14th March the short interest totalled 19,016,567 shares which is a decrease of 24.7%.
Endo Health Solutions (NASDAQ:ENDP) the results announced
Endo Health Solutions (NASDAQ:ENDP) announced its results on 28th Feb and has reported an earnings of $0.96 per share for the quarter. The revenue that the company generated was $584.95 million for that quarter. The overall revenue of the company was down by 26.8% over the period of few years.
The recent analysis for Endo Health Solutions (NASDAQ:ENDP)
ENDP has been a subject for researches by various analysts. The analyst at Leerink Swann has raised the price target for Endo Health Solutions (NASDAQ:ENDP) from $77.00 to $85.00. The analyst at Zack has given a neutral rating to ENDP and has a price target of 81$ for the stock. The analysts at FBR Capital Markets have raised the target price from $52.00 to $82.00 and have given a market perform rating to the stock. Two analysts have rated the stock as a sell, eleven have rated it as a hold and five of them have issued a rating of a buy.